Ca2+/calmodulin signaling in NMDA-induced synaptic plasticity

Critical Reviews in Neurobiology

Volumn 14, Issue 2, 2000, Pages 91-129

  Gnegy, M E ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Amphetamine; Hippocampus; Long term potentiation; Nucleus accumbens; Sensitization; Striatum; Ventral tegmental area

Indexed keywords

CALCIUM ION; CALMODULIN; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; CALCIUM; GLUTAMIC ACID;

CALCIUM MOBILIZATION; CALCIUM SIGNALING; CELL MEMBRANE PERMEABILITY; CORPUS STRIATUM; HIPPOCAMPUS; HUMAN; LONG TERM POTENTIATION; NERVE CELL EXCITABILITY; NERVE CELL PLASTICITY; NEUROBIOLOGY; NONHUMAN; NUCLEUS ACCUMBENS; REVIEW; SIGNAL TRANSDUCTION; VENTRAL TEGMENTUM; ANIMAL; BRAIN; PHYSIOLOGY; RAT; SYNAPSE;

ANIMALS; BRAIN; CALCIUM; CALCIUM SIGNALING; CALMODULIN; GLUTAMIC ACID; NEURONAL PLASTICITY; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; SYNAPSES;

EID: 0034351132     PISSN: 08920915     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (402)

1. The long and short of long-term memory
2. Physiology and biochemistry of Drosophila learning mutants
3. Long-term potentiation-a decade of progress?
4. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants
5. Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis
6. The neural basis of drug craving: An incentive-sensitization theory of addiction
7. A role for sensitization in craving and relapse in cocaine addiction
8. Calcium- and activity-dependent synaptic plasticity
9. Calmodulin
10. Calmodulin: Effects of cell stimuli and drugs on cellular activation
11. Glutamate receptors and gene induction: Signalling from receptor to nucleus
12. Regulation of gene expression in hippocampal neurons by distinct calcium signaling pathways
13. Dendritic calcium dynamics
14. The postsynaptic density at glutamatergic synapses
15. Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95
16. 2+-insensitive adenylyl cyclases in the rat brain
17. NMDAR1 glutamate receptor subunit isoforms in neostriatal, neocortical, and hippocampal nitric oxide synthase neurons
18. Dynamic control of CaMKII translocation and localization in hippocampal neurons by NMDA receptor stimulation
19. Translocation of calmodulin to the nucleus supports CREB phosphorylation in hippocampal neurons
20. Regulation of nitric oxide synthase activity in cortical slices by excitatory amino acids and calcium
21. nMDA receptor activation increases cyclic AMP in area CA1 of the hippocampus via calcium/calmodulin stimulation of adenylyl cyclase
22. Involvement of a calcineurin/inhibitor-1 phosphatase cascade in hippocampal long-term depression
23. 2+ and Ras signalling pathways
24. 2+-dependent routes to Ras: Mechanisms for neuronal survival, differentiation, and plasticity
25. ras
26. 2+-regulated transcription factor phosphorylated by calmodulin-dependent kinases
27. 2+ channel-regulated neuronal gene expression
28. 2+/calmodulin-dependent protein kinases type II and type IV involves phosphorylation of a site that negatively regulates activity
29. Calcium-regulated phosphorylation within the leucine zipper of C/EBPβ
30. Inactivation of NMDA receptors by direct interaction of calmodulin with the NR1 subunit
31. Calmodulin mediates calcium-dependent inactivation of N-methyl-D-aspartate receptors
32. 2+ and ATP
33. Competitive binding of α-actinin and calmodulin to the NMDA receptor
34. Calcium-induced actin depolymerization reduces NMDA channel activity
35. Caldesmon, a calmodulin-binding, F actin-interacting protein, is present in aorta, uterus and platelets
36. Adducin regulation-Definition of the calmodulin-binding domain and sites of phosphorylation by protein kinase A and C
37. The MARCKS family of cellular protein kinase C substrates
38. 2+-dependent flip-flop manner: Survey in brain and secretory tissues
39. (2+)-dependent phosphatase
40. Synaptic desensitization of NMDA receptors by calcineurin
41. Calcineurin regulation of synaptic function: From ion channels to transmitter release and gene transcription
42. 2+/calmodulin-dependent protein kinases
43. Dual role of calmodulin in autophosphorylation of multifunctional CaM kinase may underlie decoding of calcium signals
44. Calmodulin trapping by calcium-calmodulin-dependent protein kinase
45. Temporal limits on the rise in postsynaptic calcium required for the induction of long-term potentiation
46. Calcium/calmodulin-dependent protein kinase II is associated with the N-methyl-D-aspartate receptor
47. Autophosphorylation-dependent targeting of calcium/calmodulin-dependent protein kinase II by the NR2B subunit of the N-methyl-D-aspartate receptor
48. AlphaCaMKII binding to the C-terminal tail of NMDA receptor subunit NR2A and its modulation by autophosphorylation
49. Mechanism and regulation of calcium/calmodulin-dependent protein kinase II targeting to the NR2B subunit of the N-methyl-D-aspartate receptor
50. Excitatory interactions between glutamate receptors and protein kinases
51. 2+-calmodulin in intact cells
52. RC3/neurogranin, a postsynaptic calpacitin for setting the response threshold to calcium influxes
53. Unconventional myosins
54. Brain myosin-V, a calmodulin-carrying myosin, binds to calmodulin-dependent protein kinase II and activates its kinase activity
55. Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path
56. Toward a molecular explanation for long-term potentiation
57. An essential role for postsynaptic calmodulin and protein kinase activity in long-term potentiation
58. 2+/calmodulin-dependent protein kinase II
59. (2+)/calmodulin-dependent protein kinase II via dendritic protein synthesis in hippocampal neurons
60. Potentiated transmission and prevention of further LTP by increased CaMKII activity in postsynaptic hippocampal slice neurons
61. Calcium calmodulin-dependent kinase II and long-term potentiation enhance synaptic transmission by the same mechanism
62. 2+/CaM pathways in hippocampal CA1 neurons
63. αCalcium/calmodulin kinase II mutant mice: Deficient long-term potentiation and impaired spatial learning
64. CA1 long-term potentiation is diminished but present in hippocampal slices from alpha-CaMKII mutant mice
65. Control of memory formation through regulated expression of a CaMKII transgene
66. 286 of the alpha calcium-calmodulin kinase II in LTP and learning
67. Abnormal hippocampal spatial representations in αCaMKIIT286A and CREBαδ-mice
68. Mice expressing activated CaMKII lack low-frequency LTP and do not form stable place cells in the CA1 region of the hippocampus
69. Importance of AMPA receptors for hippocampal synaptic plasticity but not for spatial learning
70. 2+ permeability of AMPA receptors in principal neurons and interneurons in rat CNS
71. Characterization of multiple phosphorylation sites on the AMPA receptor GluR1 subunit
72. Phosphorylation of the alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor GluR1 subunit by calcium/calmodulin-dependent kinase II
73. 2+/calmodulin-dependent protein kinase II regulatory phosphorylation site in the alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate-type glutamate receptor
74. Driving AMPA receptors into synapses by LTP and CaMKII: Requirement for GluR1 and PDZ domain interaction
75. 2+/calmodulin-kinase II enhances channel conductance of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate-type glutamate receptors
76. Modulation of AMPA receptor unitary conductance by synaptic activity
77. Regulation of ligand-gated ion channels by protein phosphorylation
78. Control of GluR1 AMPA receptor function by cAMP-dependent protein kinase
79. Regulation of distinct AMPA receptor phosphorylation sites during bidirectional synaptic plasticity
80. The biochemistry of memory: A new and specific hypothesis
81. Rapid spine delivery and redistribution of AMPA receptors after synaptic NMDA receptor activation
82. LTP mechanisms: From silence to four-lane traffic
83. Transient and enduring morphological correlates of synaptic activity and efficacy change in the rat hippocampal slice
84. Rapid dendritic morphogenesis in CA1 hippocampal dendrites induced by synaptic activity
85. Dendritic spine changes associated with hippocampal long-term synaptic plasticity
86. LTP promotes formation of multiple spine synapses between a single axon terminal and a dendrite
87. CaMKII regulates the density of central glutamatergic synapses in vivo
88. Postsynaptic calcium/calmodulin-dependent protein kinase II is required to limit elaboration of presynaptic and postsynaptic neuronal arbors
89. Regulation of DLG localization at synapses by CaMKII-dependent phosphorylation
90. Enhanced long-term potentiation and impaired learning in mice with mutant postsynaptic density-95 protein
91. Peptide inhibitors of PKC and CaMK block induction but not expression of long-term potentiation
92. Inhibition of postsynaptic PKC or CaMKII blocks induction but not expression of LTP
93. Persistent protein kinase activity underlying long-term potentiation
94. Protein kinase C injection into hippocampal pyramidal cells elicits features of long-term potentiation
95. Modified hippocampal long-term potentiation in PKC gamma-mutant mice
96. Roles of metabotropic glutamate receptors in LTP and LTD in the hippocampus
97. Long-lasting enhancement of NMDA receptor-mediated synaptic transmission by metabotropic glutamate receptor activation
98. Selective abolition of the NMDA component of long-term potentiation in mice lacking mGluR5
99. Metaplasticity: The plasticity of synaptic plasticity
100. Involvement of calcium/calmodulin-dependent protein kinases in the setting of a molecular switch involved in hippocampal LTP
101. Muscarinic receptor-mediated translocation of calmodulin in SK-N-SH human neuroblastoma cells
102. Effect of continuous phorbol ester treatment on muscarinic receptor-mediated calmodulin redistribution in SK-N-SH neuroblastoma cells
103. 2+/calmodulin-dependent protein kinase
104. In CA1 pyramidal neurons of the hippocampus protein kinase C regulates calcium-dependent inactivation of NMDA receptors
105. Localization of the protein kinase C phosphorylation/calmodulin-binding substrate RC3 in dendritic spines of neostriatal neurons
106. Enhanced phosphorylation of the postsynaptic protein kinase C substrate RC3/neurogranin during long-term potentiation
107. Activation of metabotropic glutamate receptors increases endogenous protein kinase C substrate phosphorylation in adult hippocampal slices
108. Long-term potentiation and synaptic protein phosphorylation
109. Temporal differences in the phosphorylation state of pre- and postsynaptic protein kinase C substrates B-50/GAP-43 and neurogranin during long-term potentiation
110. Involvement of neurogranin in the modulation of calcium/calmodulin-dependent protein kinase II, synaptic plasticity, and spatial learning: A study with knockout mice
111. Antibodies to postsynaptic PKC substrate neurogranin prevent long-term potentiation in hippocampal CA1 neurons
112. Calcium-promoted translocation of protein kinase C to synaptic membranes: Relation to the phosphorylation of an endogenous substrate (protein F1) involved in synaptic plasticity
113. Protected-site phosphorylation of protein kinase C in hippocampal long-term potentiation
114. Identification and localization of an actin-binding motif that is unique to the epsilon isoform of protein kinase C and participates in the regulation of synaptic function
115. Protein kinase C beta II specifically binds to and is activated by F-actin
116. 2+-independent form of kinase C in long-term potentiation
117. Autonomously active protein kinase C in the maintenance phase of N-methyl-D-aspartate receptor-independent long-term potentiation
118. (2+)-induced persistent protein kinase C activation in rat hippocampal homogenates
119. Memory and the brain: Unexpected chemistries and a new pharmacology
120. The protease inhibitor leupeptin interferes with the development of LTP in hippocampal slices
121. NMDA receptor-mediated regulation of AMPA receptor properties in organotypic hippocampal slice cultures
122. Brain spectrin, calpain and long-term changes in synaptic efficacy
123. Calmodulin and calcium-dependent protease I coordinately regulate the interaction of fodrin with actin
124. Cyclic 3′,5′-nucleotide phosphodiesterase. Demonstration of an activator
125. Calcium-dependent phosphodiesterase activity and its activating factor (PAF) from brain studies on cyclic 3′,5′-nucleotide phosphodiesterase
126. Identification of a calcium-binding protein as a calcium-dependent regulator of brain adenylate cyclase
127. 2+-sensitive adenylyl cyclases
128. Multiple cyclic nucleotide phosphodiesterases
129. Activation of NMDA receptors induces dephosphorylation of DARPP-32 in rat striatal slices
130. Protein phosphatase 1 modulation of neostriatal AMPA channels: Regulation by DARPP-32 and spinophilin
131. Calmodulin-stimulated adenylate cyclases
132. Calcium-stimulated adenylyl cyclase activity is critical for hippocampus-dependent long-term memory and late-phase LTP
133. Gating of CaMKII by cAMP-regulated protein phosphatase activity during LTP
134. 2+/calmodulin-dependent kinase II autophosphorylation
135. Immunohistochemical localization of adenylyl cyclase in rat brain indicates a highly selective concentration at synapses
136. Protein kinase and phosphatase activity regulate the form of synaptic plasticity expressed
137. 2+ and stimulus duration-dependent switch for hippocampal gene expression
138. Persistence of the interaction of calmodulin with adenylyl cyclase: Implications for integration of transient calcium stimuli
139. Temporal asymmetry in activation of Aplysia adenylyl cyclase by calcium and transmitter may explain temporal requirements of conditioning
140. 2+ and isoproterenol
141. 2+/calmodulin-stimulable adenylyl cyclases as molecular coincidence detectors in memory formation
142. Regulation of calmodulin-sensitive adenylate cyclase by the stimulatory G-protein, Gs*
143. s-coupled receptors in vivo
144. D1/D5 receptor agonists induce a protein synthesis-dependent late potentiation in the CA1 region of the hippocampus
145. Dopaminergic antagonists prevent long-term maintenance of posttetanic LTP in the CA1 region of rat hippocampal slices
146. Protein kinase A inhibitors prevent the maintenance of hippocampal long-term potentiation
147. 1-deficient mutant mice do not express the late phase of hippocampal long-term potentiation
148. Signaling from synapse to nucleus: Postsynaptic CREB phosphorylation during multiple forms of hippocampal synaptic plasticity
149. Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein
150. Induction of CRE-mediated gene expression by stimuli that generate long-lasting LTP in area CA1 of the hippocampus
151. 2+ stimulation of CREB-dependent transcription and ERK nuclear translocation
152. VDCCs and NMDARs underlie two forms of LTP in CA1 hippocampus in vivo
153. 2+/calmodulin-dependent protein kinase type IV/Gr-deficient mice
154. mRNA localization in neurons: A multipurpose mechanism?
155. 2+/calmodulin-dependent protein kinase II within postsynaptic dendritic spines of cultured hippocampal neurons
156. (2+)/calmodulin-dependent protein kinase II and mitogen-activated protein kinase activation in hippocampal long-term potentiation
157. A requirement for the mitogen-activated protein kinase cascade in hippocampal long-term potentiation
158. Making new connections: Role of ERK/MAP kinase signaling in neuronal plasticity
159. A role for the Ras signalling pathway in synaptic transmission and long-term memory
160. The mitogen-activated protein kinase cascade couples PKA and PKC to cAMP response element binding protein phosphorylation in area CA1 of hippocampus
161. A requirement for the intercellular messenger nitric oxide in long-term potentiation
162. Nitric oxide synthase inhibitors block long-term potentiation induced by weak but not strong tetanic stimulation at physiological brain temperatures in rat hippocampal slices
163. The suppression of long-term potentiation in rat hippocampus by inhibitors of nitric oxide synthase is temperature- and age-dependent
164. Nitric oxide signaling contributes to late-phase LTP and CREB phosphorylation in the hippocampus
165. Possible involvement of nitric oxide in long-term potentiation
166. Nitric oxide and carbon monoxide produce activity-dependent long-term synaptic enhancement in hippocampus
167. Nitric oxide facilitates long-term potentiation, but not long-term depression
168. Long-term potentiation is reduced in mice that are doubly mutant in endothelial and neuronal nitric oxide synthase
169. Retrograde messengers and long-term potentiation: A progress report
170. Presynaptic enhancement shown by whole-cell recordings of long-term potentiation in hippocampal slices
171. Presynaptic component of long-term potentiation visualized at individual hippocampal synapses
172. Redistribution of synaptic vesicles during long-term potentiation in the hippocampus
173. Direct relation of long-term synaptic potentiation to phosphorylation of membrane protein F1, a substrate for membrane protein kinase C
174. Phosphorylation of B-50 (GAP43) is correlated with neurotransmitter release in rat hippocampal slices
175. The protein kinase C and protein kinase C-related gene families
176. Neurite outgrowth stimulated by neural cell adhesion molecules requires growth-associated protein-43 (GAP-43) function and is associated with GAP-43 phosphorylation in growth cones
177. Enhanced learning after genetic overexpression of a brain-growth protein
178. 2+/calmodulin-dependent protein kinase II phosphorylation of the presynaptic protein synapsin I is persistently increased during long-term potentiation
179. 2+/calmodulin-dependent protein kinase II and its endogenous substrates in the induction of long-term potentiation
180. Synaptic vesicle phosphoproteins and regulation of synaptic function
181. Effects of the neuronal phosphoprotein synapsin I on actin polymerization. I. Evidence for a phosphorylation-dependent nucleating effect
182. 2+/calmodulin-dependent protein kinase in the rat hippocampal slice
183. Short-term synaptic plasticity is altered in mice lacking synapsin I
184. Distinct pools of synaptic vesicles in neurotransmitter release
185. Essential functions of synapsins I and II in synaptic vesicle regulation
186. 2+-dependent interaction of the growth-associated protein GAP-43 with the synaptic core complex
187. The neuronal growth-associated protein GAP-43 interacts with rabaptin-5 and participates in endocytosis
188. Presynaptic PKC substrate B-50 (GAP-43) and neurotransmitter release: Studies with permeated synaptosomes
189. Dopaminergic antagonists prevent long-term maintenance of posttetanic LTP in the CA1 region of rat hippocampal slices
190. Integrity of the mesocortical dopaminergic system is necessary for complete expression of in vivo hippocampal-prefrontal cortex long-term potentiation
191. 5 receptor and beta-adrenergic receptor contributions to the persistence of long-term potentiation
192. D1/D5 dopamine receptor activation increases the magnitude of early long-term potentiation at CA1 hippocampal synapses
193. Retrograde messengers, long-term potentiation and memory
194. Arachidonic acid, but not sodium nitroprusside, stimulates presynaptic protein kinase C and phosphorylation of GAP-43 in rat hippocampal slices and synaptosomes
195. Nitric oxide and synaptic function
196. Mediation of classical conditioning in Aplysia californica by long-term potentiation of sensorimotor synapses
197. Behavioral pharmacology of amphetamine
198. Enhanced response to repeated d-amphetamine challenge: Evidence for behavioral sensitization in humans
199. Progressive behavioral response to repeated d-amphetamine challenge: Further evidence for sensitization in humans
200. Acute exacerbation of methamphetamine psychosis and lasting dopaminergic supersensitivity-a clinical survey
201. Cellular mechanisms of behavioral sensitization to drugs of abuse
202. Long-lasting effects of escalating doses of d-amphetamine on brain monoamines, amphetamine-induced stereotyped behavior and spontaneous nocturnal locomotion
203. Amphetamine-induced time-dependent sensitization of dopamine neurotransmission in the dorsal and ventral striatum: A microdialysis study in behaving rats
204. The neurobiology of amphetamine psychosis: Evidence from studies with an animal model
205. The pharmacology and neural circuitry of sensitization to psychostimulants
206. Neuroadaptations involved in amphetamine and cocaine addiction
207. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants
208. Sensitization and individual differences to IP amphetamine, cocaine, or caffeine following repeated intracranial amphetamine infusions
209. Amphetamine injection into the ventral mesencephalon sensitizes rats to peripheral amphetamine and cocaine
210. Amphetamine injected into the ventral tegmental area sensitizes the nucleus accumbens dopaminergic response to systemic amphetamine: An in vivo microdialysis study in the rat
211. Amphetamine injected into the ventral tegmental area sensitizes the nucleus accumbens dopaminergic response to systemic amphetamine: An in vivo microdialysis study in the rat
212. Amphetamine administered to the ventral tegmental area sensitizes rats to the locomotor effects of nucleus accumbens amphetamine
213. Microinjections of SCH-23390 into the ventral tegmental area and substantia nigra pars reticulata attenuate the development of sensitization to the locomotor activating effects of systemic amphetamine
214. The effect of dopamine receptor blockade on the development of sensitization to the locomotor activating effects of amphetamine and morphine
215. 1 dopamine receptor activation is necessary for the induction of sensitization by amphetamine in the ventral tegmental area
216. 1 receptors of the ventral tegmental area in the behavioral sensitization induced by intraventral tegmental area injections of D-amphetamine
217. 1 receptor antagonist SCH 23390 retards methamphetamine sensitization in both combined administration and early posttreatment schedules in mice
218. Blockade of "reverse tolerance" to cocaine and amphetamine by MK-801
219. Amphetamine behavioral sensitization and the excitatory amino acids
220. Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine
221. Coadministration of MK-801 with amphetamine, cocaine or morphine prevents rather than transiently masks the development of behavioral sensitization
222. Effects of daily cocaine and morphine treatment on somatodendritic and terminal field dopamine release
223. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity
224. Development of both conditioning and sensitization of the behavioral activating effects of amphetamine is blocked by the noncompetitive NMDA receptor antagonist, MK-801
225. Competitive and noncompetitive NMDA antagonists block sensitization to methamphetamine
226. NMDA receptor-mediated expression of Fos protein in the rat striatum following methamphetamine administration: Relation to behavioral sensitization
227. Evidence for involvement of ventral tegmental area cyclic AMP systems in behavioral sensitization to psychostimulants
228. The pharmacology of mesolimbic dopamine neurons: A dual-probe microdialysis study in the ventral tegmental area and nucleus accumbens of the rat brain
229. Properties and plasticity of excitatory synapses on dopaminergic and GABAergic cells in the ventral tegmental area
230. 1 receptors facilitate transmitter release
231. Expression of glutamate receptor subunit/subtype messenger RNAs for NMDAR1, GLuR1, GLuR2 and mGLuR5 by accumbal projection neurons
232. Long-term potentiation at excitatory amino acid synapses on midbrain dopamine neurons
233. Sensitization to cocaine's motor activating properties produced by electrical kindling of the medial prefrontal cortex but not of the hippocampus
234. Modulation of long-term depression by dopamine in the mesolimbic system
235. Synaptic plasticity: LTP and LTD
236. Synaptic plasticity and physiological interactions between dopamine and glutamate in the striatum
237. An essential role for protein phosphatases in hippocampal long-term depression
238. Involvement of a calcineurin/inhibitor-1 phosphatase cascade in hippocampal long-term depression
239. The role of calcium-calmodulin kinase II in three forms of synaptic plasticity
240. Regulation of neuronal plasticity in the central nervous system by phosphorylation and dephosphorylation
241. Amphetamine blocks long-term synaptic depression in the ventral tegmental area
242. Immunocytochemical localization of the dopamine transporter in human brain
243. Acute and repeated systemic amphetamine administration: Effects on extracellular glutamate, aspartate, and serine levels in rat ventral tegmental area and nucleus accumbens
244. Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity
245. Inhibition of nitric oxide synthase does not block the development of sensitization to the behavioral activating effects of amphetamine
246. Nitric oxide facilitates N-methyl-D-aspartate-induced burst firing in dopamine neurons from rat midbrain slices
247. Chronic administration of (+)-amphetamine alters the reactivity of midbrain dopaminergic neurons to prefrontal cortex stimulation in the rat
248. Metabotropic glutamate receptors and the generation of locomotor activity: Interactions with midbrain dopamine
249. Effects of the AMPA receptor antagonist NBQX on the development and expression of behavioral sensitization to cocaine and amphetamine
250. DNQX blockade of amphetamine behavioral sensitization
251. Metabotropic glutamate receptors are necessary for sensitization by amphetamine
252. Cellular localization of a metabotropic glutamate receptor in rat brain
253. Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat
254. Drug abuse: Hedonic homeostatic dysregulation
255. Addictive drugs and brain stimulation reward
256. Synaptic plasticity in an in vitro slice preparation of the rat nucleus accumbens
257. Simultaneous LTP of non-NMDA- and LTD of NMDA-receptor-mediated responses in the nucleus accumbens
258. 1 agonist C-APB in mice
259. Intranigral injections of SCH 23390 inhibit amphetamine-induced rotational behavior
260. 2 antagonist
261. The amphetamine-conditioned place preference: Differential involvement of dopamine receptor subtypes and two dopaminergic terminal areas
262. 1 dopamine receptor blockade prevents the facilitation of amphetamine self-administration induced by prior exposure to the drug
263. Role of D-1 and D-2 receptor stimulation in sensitization to amphetamine-induced circling behavior and in expression and extinction of the Pavlovian conditioned response
264. Amphetamine regulates gene expression in rat striatum via transcription factor CREB
265. Differential vulnerability of primate caudate-putamen and striosome-matrix dopamine systems to the neurotoxic effects of L-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine
266. 2 dopamine receptor antagonists on acute amphetamine- or methamphetamine-induced upregulation of zif/268 mRNA expression in rat forebrain
267. 2 striatal neurons
268. c-fos antisense generates apomorphine- and amphetamine-induced rotation
269. Medial prefrontal cortical injections of c-fos antisense oligonucleotides transiently lower c-Fos protein and mimic amphetamine withdrawal behaviours
270. Calcium channel blocking drugs in the management of drug dependence, withdrawal and craving. A clinical pilot study with nifedipine and verapamil
271. Isradipine, a dihydropyridine-class calcium channel antagonist, attenuates some of d-methamphetamine's positive subjective effects: A preliminary study
272. Calcium channel blockers and behavioral sensitization
273. Effects of calcium channel entry blockers on cocaine- and amphetamine-induced motor activities and toxicities
274. The importance of calcium in amphetamine-induced turning behavior in mice with unilateral nigro-striatal lesions
275. Effect of L-type calcium channel modulators on stimulant-induced hyperactivity
276. 1 dopaminergic protein kinase/phosphatase cascade in rat neostriatal neurons
277. 2+/calmodulin binds to and modulates P/Q-type calcium channels
278. Calmodulin supports both inactivation and facilitation of L-type calcium channels
279. 2+-dependent inactivation of L-type calcium channels
280. Effects of chronic amphetamine treatment on the glutamate concentration in cerebrospinal fluid and brain: Implications for a theory of schizophrenia
281. Repeated administration of cocaine or amphetamine alters neuronal responses to glutamate in the mesoaccumbens dopamine system
282. Withdrawal from repeated amphetamine administration reduces NMDAR1 expression in the rat substantia nigra, nucleus accumbens and medial prefrontal cortex
283. Repeated amphetamine administration alters AMPA receptor subunit expression in rat nucleus accumbens and medial prefrontal cortex
284. Repeated cocaine alters glutamate receptor subunit levels in the nucleus accumbens and ventral tegmental area of rats that develop behavioral sensitization
285. Metabotropic glutamate receptor activation produces extrapyramidal motor system activation that is mediated by striatal dopamine
286. Regulation of locomotor activity by metabotropic glutamate receptors in the nucleus accumbens and ventral tegmental area
287. Metabotropic glutamate receptors and the generation of locomotor activity: Interactions with midbrain dopamine
288. Activation of metabotropic glutamate receptors in the rat nucleus accumbens increases locomotor activity in a dopamine-dependent manner
289. The metabotropic glutamate receptor antagonist (RS)-MCPG produces hyperlocomotion in amphetamine pre-exposed rats
290. Behavioral sensitization is accompanied by an enhancement in amphetamine-stimulated dopamine release from striatal tissue in vitro
291. Enhanced dopamine release and phosphorylation of synapsin I and neuromodulin in striatal synaptosomes after repeated amphetamine
292. 2+- and calmodulin-dependent phosphorylation and synaptic vesicles
293. Time course of the development of the enhanced behavioral and biochemical responses to amphetamine after pretreatment with amphetamine
294. Calcium dependence of sensitised dopamine release in rat nucleus accumbens following amphetamine challenge: Implications for the disruption of latent inhibition
295. Subchronic methamphetamine treatment enhances methamphetamine- or cocaine-induced dopamine efflux in vivo
296. Concomitant sensitization of amphetamine-induced behavioral stimulation and in vivo dopamine release from rat caudate nucleus
297. Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization
298. 2 receptors in modulation of rat nucleus accumbens noradrenaline release
299. Enhancement of dopamine release from striatal slices of rats that were subchronically treated with methamphetamine
300. Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats
301. In vivo microdialysis reveals a diminished amphetamine-induced DA response corresponding to behavioral sensitization produced by repeated amphetamine pretreatment
302. Reduction of dopamine release and synthesis by repeated amphetamine treatment: Role in behavioral sensitization
303. Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine
304. The release of endogenous norepinephrine and dopamine from cerebral cortex by amphetamine
305. 2+ dependence of the amphetamine, nomifensine, and Lu 19-005 effect on in vivo dopamine transmission
306. Use of calcium antagonism for the characterization of drug-evoked dopamine release from the brain of conscious rats determined by microdialysis
307. Repeated cocaine modifies the mechanism by which amphetamine releases dopamine
308. Calcium-mediated second messengers modulate the expression of behavioral sensitization to cocaine
309. A direct comparison of amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis
310. Individual differences in responsiveness to single and repeated amphetamine administration: Behavioral characteristics and neurochemical correlates
311. Effect of pretreatment with amphetamine on the interaction between amphetamine and dopamine neurons in the nucleus accumbens
312. Repeated antidepressant treatments induce a long-lasting dopamine autoreceptor subsensitivity: Is daily treatment necessary for clinical efficacy?
313. Increased in vivo phosphorylation of neuromodulin and synapsin I in striatum from rats treated with repeated amphetamine
314. Methamphetamine decreases calcium - Calmodulin-dependent protein kinase II activity in discrete rat brain regions
315. Neurochemical analysis of the tyrosine hydroxylase expression in methamphetamine-sensitized rats
316. Time course of tyrosine hydroxylase expression after behavioral sensitization to cocaine
317. Behavioral sensitization and relative hyperresponsiveness of striatal and limbic dopaminergic neurons after repeated methamphetamine treatment
318. Neurochemical effects of cocaine following acute and repeated injection
319. Chronic amphetamine: Is dopamine a link in or a mediator of the development of tolerance and reverse tolerance?
320. The long-term effects of repeated amphetamine treatment in vivo on amphetamine, KCl and electrical stimulation evoked striatal dopamine release in vitro
321. Methamphetamine-induced sensitization of dopamine release via a metabotropic glutamate receptor-mediated pathway in rat striatal slices
322. Subchronic methamphetamine treatment enhances ouabain-induced striatal dopamine efflux in vivo
323. +-stimulated dopamine release from hippocampal slices
324. Protein kinase C inhibitors block amphetamine-mediated dopamine release in rat striatal slices
325. Amphetamine-induced loss of human dopamine transporter activity: An internalization-dependent and cocaine-sensitive mechanism
326. Regulated trafficking of the human dopamine transporter. Clathrin-mediated internalization and lysosomal degradation in response to phorbol esters
327. Membrane trafficking regulates the activity of the human dopamine transporter
328. Protein kinase C regulates the interaction between a GABA transporter and syntaxin 1A
329. Amphetamine and dopamine-induced immediate early gene expression in striatal neurons depends on postsynaptic NMDA receptors and calcium
330. NMDA receptors mediate amphetamine-induced upregulation of zif/268 and preprodynorphin mRNA expression in rat striatum
331. Repeated amphetamine administration induces a prolonged augmentation of phosphorylated cyclase response element-binding protein and Fos-related antigen immunoreactivity in rat striatum
332. DeltaFosB: A molecular mediator of long-term neural and behavioral plasticity
333. The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones
334. Unilateral dopamine denervation blocks corticostriatal LTP
335. Dopamine reverses the depression of rat corticostriatal synapses which normally follows high-frequency stimulation of cortex in vitro
336. Long-term potentiation in the striatum is unmasked by removing the voltage-dependent blockade of NMDA receptor channel
337. Dopamine and cAMP-regulated phosphoprotein 32 kDa controls both striatal long-term depression and long-term potentiation, opposing forms of synaptic plasticity
338. Long-term synaptic depression in the striatum: Physiological and pharmacological characterization
339. Post-receptor mechanisms underlying striatal long-term depression
340. Expression of long-term potentiation of the striatum in methamphetamine-sensitized rats
341. DARPP-32: Regulator of the efficacy of dopaminergic neurotransmission
342. Beyond the dopamine receptor: The DARPP-32/protein phosphatase-1 cascade
343. Regulation of phosphorylation of the GluR1 AMPA receptor in the neostriatum by dopamine and psychostimulants in vivo
344. Characterization of protein kinase A and protein kinase C phosphorylation of the N-methyl-D-aspartate receptor NR1 subunit using phosphorylation site-specific antibodies
345. Regulated subcellular distribution of the NR1 subunit of the NMDA receptor
346. Immunocytochemical localization of calmodulin in regions of rodent brain
347. High levels of a heat-labile calmodulin-binding protein (CaM-BP80) in bovine neostriatum
348. 2+-inhibitable adenylyl cyclase in dopaminergically innervated rat brain regions
349. 2+/calmodulin-dependent protein kinase II from postsynaptic densities
350. 2+/calmodulin-dependent protein kinase II
351. Alterations in calmodulin content of rat brain areas after chronic application of haloperidol and amphetamine
352. Influence of dopamine receptor agonists and antagonists on calmodulin translocation in different brain regions
353. Alterations in calmodulin content and localization in areas of rat brain after repeated intermittent amphetamine
354. Alterations in calmodulin mRNA expression and calmodulin content in rat brain after repeated, intermittent amphetamine
355. Chronic amphetamine treatment increases striatal calmodulin in rats
356. Acute and repeated amphetamine differentially alters calmodulin content and calmodulin mRNAs in rat brain
357. Haloperidol and MK-801 block increases in striatal and limbic forebrain calmodulin resulting from repeated amphetamine treatment
358. Early post-treatment with haloperidol retards induction of methamphetamine sensitization in mice
359. Inhibition of methamphetamine sensitization by post-methamphetamine treatment with SCH 23390 or haloperidol
360. Cocaine-induced behavioral sensitization: Effects of haloperidol and SCH 23390 treatments
361. The effect of environment on the changes in calmodulin in rat brain produced by repeated amphetamine treatment
362. Molecular analysis of human and rat calmodulin complementary DNA clones. Evidence for additional active genes in these species
363. Differential calmodulin gene expression in fetal, adult, and neoplastic tissues of rodents
364. Acute and chronic amphetamine treatments differently regulate neuropeptide messenger RNA levels and Fos immunoreactivity in rat striatal neurons
365. Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine
366. Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine
367. Changes in dendritic spine morphology in response to increased availability of monoamines in rat medial prefrontal cortex
368. Amphetamine changes neostriatal morphology
369. The effects of amphetamine on synaptic plasticity in rat's medial prefrontal cortex
370. CaM I mRNA is localized to apical dendrites during postnatal development of neurons in the rat brain
371. Localization of the multiple calmodulin messenger RNAs in differentiated PC12 cells
372. Amphetamine withdrawal alters bistable states and cellular coupling in rat prefrontal cortex and nucleus accumbens neurons recorded in vivo
373. Calmodulin in neurotransmitter and hormone action
374. 2+-regulated protein activator of cAMP phosphodiesterase
375. Repeated haloperidol increases both calmodulin and a calmodulin-binding protein in rat striatum
376. Cocaine-induced supersensitivity of striatal dopamine receptors: Role of endogenous calmodulin
377. Effects of acute and chronic morphine treatment of calmodulin activity of rat brain
378. Differential response of calmodulin genes in the mouse brain after systemic kainate administration
379. 2+/calmodulin signaling system in the neural response to excitability. Involvement of neuronal and glial cells
380. Modulation of transcription factor Sp1 by cAMP-dependent protein kinase
381. Structural organization of multiple rat calmodulin genes
382. Presence of calcium/calmodulin-dependent protein kinase II in nerve terminals of rat brain
383. Comparative study of the distribution of calmodulin kinase II and calcineurin in the mouse brain
384. 2+/calmodulin-dependent protein kinase II alpha and beta isoforms in the brainstem of the rat
385. Anatomical localization of calmodulin mRNA in the rat brain with cloned cDNA and synthetic oligonucleotide probes
386. Regional distribution of calmodulin activity in rat brain
387. Ultrastructural localization and comparative distribution of nitric oxide synthase and N-methyl-D-aspartate receptors in the shell of the rat nucleus accumbens
388. Differential regulation by calmodulin of basal, GTP- and dopamine-stimulated adenylate cyclase acti-vities in bovine striatum
389. Distribution of mRNA for the calmodulin-sensitive adenylate cyclase in rat brain: Expression in areas associated with learning and memory
390. Adenylyl cyclases: mRNA and characteristics of enzyme activity in three areas of brain
391. 3H]dopamine release from rat hippocampal slices through sigma-1 binding sites
392. 1-mediated turning behavior and striatal c-fos expression
393. Regulation of neurotransmitter interactions in the ventral striatum
394. Dopamine neurons make glutamatergic synapses in vitro
395. Mechanisms of typical and atypical antipsychotic drug action in relation to dopamine and NMDA receptor hypofunction hypotheses of schizophrenia
396. Biological research on schizophrenia
397. Dopamine/glutamate interactions in Parkinson's disease
398. Glutamate-dopamine interactions in the basal ganglia: Relationship to Parkinson's disease
399. NMDA receptor involvement in two animal models of Parkinson's disease
400. Blockade of behavioral sensitization to cocaine and amphetamine by inhibitors of protein synthesis
401. Effects of cAMP simulate a late stage of LTP in hippocampal CA1 neurons
402. A macromolecular synthesis-dependent late phase of long-term potentiation requiring cAMP in the medial perforant pathway of rat hippocampal slices